ASHLEY LARANJO: Open Payments
NPI 1831668243 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,954 in 100 payments from 28 companies in 2025. Trend: 2023 $158 · 2024 $901 · 2025 $9,954
Speaker / faculty: $5,920Food & beverage: $2,514Travel & lodging: $1,520
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 11 | $7,639 |
| Amgen Inc. | 16 | $440 |
| Corcept Therapeutics | 6 | $304 |
| Novo Nordisk Inc | 13 | $303 |
| KYOWA KIRIN, INC. | 4 | $202 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $138 |
| Lilly USA, LLC | 5 | $115 |
| Xeris Pharmaceuticals, Inc. | 5 | $114 |
| Amneal Pharmaceuticals LLC | 3 | $70 |
| Tandem Diabetes Care, Inc. | 4 | $60 |
Products named: DEXCOM G7 GSS (161), EVENITY, Korlym, Ozempic, CRYSVITA, Kerendia, Dexcom G6 Transmitter, RECORLEV.
Industry payments across MA — which companies pay providers there.
